Cacti Asset Management Lifted By $1.17 Million Its American Express Co (AXP) Stake; Lemaitre Vascular Has 1.71 Sentiment

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company has market cap of $657.51 million. The firm provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable removal of varicose veins. It has a 43.7 P/E ratio. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature.

Cacti Asset Management Llc increased American Express Co (AXP) stake by 2.36% reported in 2017Q3 SEC filing. Cacti Asset Management Llc acquired 13,155 shares as American Express Co (AXP)’s stock declined 3.65%. The Cacti Asset Management Llc holds 571,507 shares with $51.14M value, up from 558,352 last quarter. American Express Co now has $79.61 billion valuation. The stock increased 3.83% or $3.38 during the last trading session, reaching $91.72. About 8.02M shares traded or 116.62% up from the average. American Express Company (NYSE:AXP) has risen 22.41% since February 11, 2017 and is uptrending. It has outperformed by 5.71% the S&P500.

Analysts await LeMaitre Vascular, Inc. (NASDAQ:LMAT) to report earnings on February, 20. They expect $0.19 EPS, up 46.15% or $0.06 from last year’s $0.13 per share. LMAT’s profit will be $3.66 million for 44.91 P/E if the $0.19 EPS becomes a reality. After $0.25 actual EPS reported by LeMaitre Vascular, Inc. for the previous quarter, Wall Street now forecasts -24.00% negative EPS growth.

Since January 1, 0001, it had 0 buys, and 4 insider sales for $4.60 million activity.

Ratings analysis reveals 0 of Lemaitre Vascular’s analysts are positive. Out of 2 Wall Street analysts rating Lemaitre Vascular, 0 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. LMAT was included in 2 notes of analysts from September 22, 2016. The stock of LeMaitre Vascular, Inc. (NASDAQ:LMAT) earned “Mkt Perform” rating by Barrington Research on Wednesday, February 22. On Thursday, September 22 the stock rating was downgraded by Sidoti to “Neutral”.

The stock increased 1.85% or $0.62 during the last trading session, reaching $34.13. About 160,497 shares traded or 22.46% up from the average. LeMaitre Vascular, Inc. (LMAT) has risen 101.07% since February 11, 2017 and is uptrending. It has outperformed by 84.37% the S&P500.

Awm Investment Company Inc. holds 3.67% of its portfolio in LeMaitre Vascular, Inc. for 561,768 shares. Perkins Capital Management Inc owns 77,075 shares or 3.02% of their US portfolio. Moreover, Thomson Horstmann & Bryant Inc has 1.66% invested in the company for 322,355 shares. The Minnesota-based Summit Creek Advisors Llc has invested 1.48% in the stock. Conestoga Capital Advisors Llc, a Pennsylvania-based fund reported 854,644 shares.

Since September 7, 2017, it had 0 buys, and 11 sales for $35.65 million activity. $2.87M worth of American Express Company (NYSE:AXP) was sold by Williams Anre D. The insider Buckminster Douglas E. sold $8.79M. Sobbott Susan sold $506,340 worth of stock or 6,000 shares. $304,962 worth of stock was sold by Zukauckas Linda on Friday, October 27. On Tuesday, December 12 Gupta Ashwini sold $5.63M worth of American Express Company (NYSE:AXP) or 56,680 shares. $1.32M worth of American Express Company (NYSE:AXP) was sold by Bush James Peter. $4.32 million worth of American Express Company (NYSE:AXP) was sold by O’Neill Michael John on Monday, December 11.

Among 36 analysts covering American Express Company (NYSE:AXP), 10 have Buy rating, 4 Sell and 22 Hold. Therefore 28% are positive. American Express Company has $130.0 highest and $54 lowest target. $95.70’s average target is 4.34% above currents $91.72 stock price. American Express Company had 106 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, January 18 by Keefe Bruyette & Woods. RBC Capital Markets maintained the shares of AXP in report on Friday, January 22 with “Underperform” rating. The rating was maintained by RBC Capital Markets on Wednesday, June 14 with “Sell”. The rating was maintained by Credit Suisse on Thursday, October 22 with “Underperform”. The firm earned “Hold” rating on Tuesday, May 30 by Jefferies. The rating was downgraded by Argus Research to “Hold” on Monday, January 25. The firm has “Neutral” rating by Bank of America given on Thursday, July 20. Argus Research maintained it with “Buy” rating and $84.0 target in Thursday, October 22 report. Morgan Stanley maintained the stock with “Equal-Weight” rating in Friday, February 2 report. Atlantic Securities initiated American Express Company (NYSE:AXP) on Friday, September 9 with “Underweight” rating.